Switch theme
Sign up to access all valuation multiples
Mauna Kea Technologies SA is a medical device corporation. It is engaged in designing, developing, and marketing an imaging platform used to view tissues at a cellular level, in real-time, during standard procedures. The firm operates in the business segment of Endomicroscopy. The group's technological platform is Cellvizio which helps physicians to detect early-stage pathologies more accurately and make therapeutic decisions. It generates revenue from the sales of Cellvizio products and accessories used for medical diagnostics, research, and related services. The company sells its products in France and internationally, of which the majority of the revenue is derived from America.
2000
98
LTM Revenue $9.0M
LTM EBITDA -$4.7M
$33.7M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Mauna Kea Technologies has a last 12-month revenue of $9.0M and a last 12-month EBITDA of -$4.7M.
In the most recent fiscal year, Mauna Kea Technologies achieved revenue of $11.3M and an EBITDA of -$1.6M.
Mauna Kea Technologies expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Mauna Kea Technologies valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $11.3M | $8.2M | XXX | XXX | XXX |
| Gross Profit | $6.1M | $5.9M | XXX | XXX | XXX |
| Gross Margin | 54% | 72% | XXX | XXX | XXX |
| EBITDA | -$1.6M | -$5.2M | XXX | XXX | XXX |
| EBITDA Margin | -14% | -63% | XXX | XXX | XXX |
| Net Profit | -$14.4M | -$12.0M | XXX | XXX | XXX |
| Net Margin | -128% | -146% | XXX | XXX | XXX |
| Net Debt | $16.9M | $27.0M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Mauna Kea Technologies's stock price is EUR 0 (or $0).
Mauna Kea Technologies has current market cap of EUR 6.6M (or $7.1M), and EV of EUR 31.4M (or $33.7M).
See Mauna Kea Technologies trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $33.7M | $7.1M | XXX | XXX | XXX | XXX | $-0.11 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Mauna Kea Technologies has market cap of $7.1M and EV of $33.7M.
Mauna Kea Technologies's trades at 3.8x LTM EV/Revenue multiple, and -7.2x LTM EBITDA.
Analysts estimate Mauna Kea Technologies's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Mauna Kea Technologies and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $33.7M | XXX | XXX | XXX |
| EV/Revenue | 4.1x | XXX | XXX | XXX |
| EV/EBITDA | -6.5x | XXX | XXX | XXX |
| P/E | -0.8x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -3.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMauna Kea Technologies's NTM/LTM revenue growth is 34%
Mauna Kea Technologies's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Mauna Kea Technologies's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Mauna Kea Technologies's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Mauna Kea Technologies and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -27% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -63% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 229% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -28% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 16% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 24% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 37% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 59% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mauna Kea Technologies acquired XXX companies to date.
Last acquisition by Mauna Kea Technologies was XXXXXXXX, XXXXX XXXXX XXXXXX . Mauna Kea Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Mauna Kea Technologies founded? | Mauna Kea Technologies was founded in 2000. |
| Where is Mauna Kea Technologies headquartered? | Mauna Kea Technologies is headquartered in France. |
| How many employees does Mauna Kea Technologies have? | As of today, Mauna Kea Technologies has 98 employees. |
| Is Mauna Kea Technologies publicy listed? | Yes, Mauna Kea Technologies is a public company listed on PAR. |
| What is the stock symbol of Mauna Kea Technologies? | Mauna Kea Technologies trades under ALMKT ticker. |
| When did Mauna Kea Technologies go public? | Mauna Kea Technologies went public in 2011. |
| Who are competitors of Mauna Kea Technologies? | Similar companies to Mauna Kea Technologies include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Mauna Kea Technologies? | Mauna Kea Technologies's current market cap is $7.1M |
| What is the current revenue of Mauna Kea Technologies? | Mauna Kea Technologies's last 12-month revenue is $9.0M. |
| What is the current EBITDA of Mauna Kea Technologies? | Mauna Kea Technologies's last 12-month EBITDA is -$4.7M. |
| What is the current EV/Revenue multiple of Mauna Kea Technologies? | Current revenue multiple of Mauna Kea Technologies is 3.8x. |
| What is the current EV/EBITDA multiple of Mauna Kea Technologies? | Current EBITDA multiple of Mauna Kea Technologies is -7.2x. |
| What is the current revenue growth of Mauna Kea Technologies? | Mauna Kea Technologies revenue growth between 2023 and 2024 was -27%. |
| Is Mauna Kea Technologies profitable? | Yes, Mauna Kea Technologies is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
